Sai Life Sciences Ltd. (SAILIFE) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹1,836 (+5.28% day change)
Key ratios
- P/E ratio
- 110.4
- P/B ratio
- 8.2
- ROE (%)
- 14.05
- ROCE (%)
- 16.63
- Debt/Equity
- 0.12
- Dividend yield (%)
- 0
- Market cap (₹ Cr)
- 39,009.92
Forensic checks
Piotroski F-Score: 6/9 · Altman Z-Score: 7.44 · Beneish M-Score: -2.5
InvestSights quality score
65.9/100 — Above Average (descriptive data-driven composite; not a recommendation)
Latest earnings call (Q1 FY27)
AI summary: The single most important signal from this call is the accelerating institutionalisation of the FTE (dedicated development team) model with large pharma — a structural shift that management explicitly compared to how China's largest CRDMOs were built. Within just 15 months of launching this model, five of six new late-phase molecules have come through FTE relationships, one…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.